BioNexus Gene Lab Corp.

BGLC | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.45

-$0.05 (-3.33%)

Sep 22, 2026, 2:05 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $3.63M

Enterprise Value $303.02K

Beta 2.21

Average Volume 100.88K

Shares Outstanding (Diluted) 2.42M

Shares Change YoY 34.55%

Institutional Ownership 0.01%

Exchange NASDAQ

ISIN US0906283066

Price Performance

Price Change 1M -4.5%

Price Change 3M -38.0%

Price Change 6M -39.8%

Price Change YTD -61.9%

Price Change 1Y -72.7%

Price Change 3Y -84.0%

Price Change 5Y -98.8%

1M CAGR (ann.) -8.5%

1Y CAGR (ann.) -73.7%

5Y CAGR (ann.) N/A

All-Time CAGR -59.6%

Valuation

PE Ratio -1.19

Forward PE N/A

PEG Ratio -0.11

Forward PEG -0.11

PS Ratio 1.16

Forward PS N/A

PB Ratio 0.47

P/FCF Ratio -4.17

P/Adj. FCF Ratio -4.17

P/OCF Ratio -4.29

EV/Sales 0.10

EV/EBIT -0.12

EV/EBITDA -0.12

EV/FCF -0.35

Earnings Yield -84.0%

FCF Yield -24.0%

Adj. FCF Yield -24.0%

Financial Health

Net Cash $3.52M

Total Debt $198.59K

Cash & Short-Term Investments $3.52M

Total Assets $8.73M

Current Ratio 6.08

Quick Ratio 5.28

Debt / Equity Ratio 0.03

Debt / EBITDA -0.08

Debt / FCF -0.23

OCF / Debt -4.24

Interest Coverage -407.16

Altman Z-Score 1.09

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 11.6%

Operating Profit Margin -82.8%

EBITDA Margin -78.0%

Net Profit Margin -82.4%

FCF Margin -27.8%

Adj. FCF Margin -27.8%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -29.5%

Return on Equity -32.9%

Return on Invested Capital -32.5%

Return on Capital Employed -32.7%

Return on Tangible Assets -29.5%

Historical Growth (CAGR)

Revenue CAGR 3Y -32.9%

Revenue CAGR 5Y -31.7%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 2.8%

EPS CAGR 5Y -48.8%

EPS CAGR 10Y N/A

FCF CAGR 3Y 28.2%

FCF CAGR 5Y -66.6%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Aug 13, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-842.37K

Free Cash Flow $-870.43K

Adj. Free Cash Flow $-870.43K

FCF Per Share -$0.36

OCF Per Share -$0.35

OCF/S Ratio -26.9%

Income Statement

Revenue $3.13M

Gross Profit $363.95K

Operating Income $-2.59M

EBITDA $-2.44M

Net Income $-2.58M

EPS (Diluted) -$1.26

Revenue / Employee $164.56K

Profit / Employee $-135.53K

Employees 19